Teleflex Declares Quarterly Dividend for Shareholders
Teleflex Incorporated (NYSE: TFX) has made a significant announcement, declaring a quarterly cash dividend of thirty-four cents ($0.34) per share for its common stock. This decision reflects the company’s ongoing commitment to return value to its investors and support their financial goals.
Understanding the Dividend Payment
The declared dividend is set to be payable on December 15 of this fiscal year. To qualify for this dividend, shareholders must be on record by the close of business on November 14. This strategic approach ensures that shareholders who invest in Teleflex can capitalize on the financial rewards alongside the company’s growth.
About Teleflex Incorporated
Teleflex is recognized globally as a leading provider of advanced medical technologies. With a mission centered around improving health and quality of life, Teleflex aims to be the most trusted partner in healthcare. The company is not only focused on profitable growth but also on fostering trusted relationships across various therapeutic areas.
Innovative Solutions Across Multiple Therapies
With an extensive portfolio, Teleflex provides essential solutions in multiple therapy domains including anesthesia, emergency medicine, interventional cardiology, radiology, surgical procedures, vascular access, and urology. This diverse range of offerings showcases Teleflex’s dedication to addressing critical healthcare needs and enhancing patient outcomes.
Empowering Healthcare with Trusted Brands
Teleflex houses several renowned brands such as Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™, and Weck™. Each of these brands represents Teleflex’s commitment to excellence and purpose-driven innovation. By leveraging the strengths of these trusted brands, Teleflex continues to shape the future of healthcare.
Looking Towards the Future
As Teleflex moves forward, the company is focused on empowering healthcare systems worldwide. The emphasis on great people and world-class products fosters innovation that can transform healthcare practices and elevate patient care standards. Teleflex encourages all stakeholders to engage with their mission and benefit from their extensive experience in medical technology.
Contact Information
For further inquiries, Teleflex’s Investor Relations can be reached through:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
Teleflex
Phone: 610-948-2836
Frequently Asked Questions
What is the newly declared dividend amount by Teleflex?
Teleflex has declared a quarterly cash dividend of $0.34 per share.
When will the dividend be paid?
The dividend is set to be paid on December 15.
What is the importance of being a shareholder by November 14?
Shareholders must be on record by November 14 to qualify for the dividend payment.
What are the core areas of healthcare that Teleflex focuses on?
Teleflex operates within areas such as anesthesia, emergency medicine, interventional cardiology, and urology, among others.
Who can I contact for more information about Teleflex's investor relations?
You can reach investor relations through Lawrence Keusch at 610-948-2836.
